European Non-invasive Prenatal Testing Market, Forecast to 2028

European Non-invasive Prenatal Testing Market, Forecast to 2028

Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe

RELEASE DATE
19-Jan-2024
REGION
Europe
Deliverable Type
Market Research
Research Code: MH32-01-00-00-00
SKU: HC_2023_537
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2023_537
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products’ non-invasive nature compared to traditional invasive prenatal testing methods like amniocentesis or chorionic villus sampling (CVS).

In recent years, the European NIPT market has displayed a notable trend toward personalized medicine. Technological innovations have led to the development of advanced NIPT tests that offer higher accuracy in detecting chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Additionally, the growing preference for early and non-invasive prenatal screening has significantly contributed to the market's expansion.

The intense competition within the NIPT industry in Europe is fueled by advancements in technology—bioinformatics, artificial intelligence, next-generation sequencing (NGS)—and the growing need for precise prenatal diagnostics. Additionally, the competitive environment becomes harsher due to broad market penetration, operational efficacy, and innovation. Rising startups are changing the industry by bringing innovative technology like exclusive platforms and AI-powered analytics to meet certain unmet demands. NIPD Genetics and other notable firms are at the forefront of innovation in the field, pioneering innovative testing.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on Europe’s NIPT Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Summary

Summary (continued)

Scope of the Study

NIPT European Country Segmentation

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Forecast Analysis

Revenue Forecast by Country

Forecast Analysis by Country

Forecast Analysis by Country (continued)

Forecast Analysis by Country (continued)

Forecast Analysis by Country (continued)

Forecast Analysis by Country (continued)

Forecast Analysis by Country (continued)

Regulatory Landscape for Europe’s NIPT Market

Europe’s NIPT Reimbursement Pathways

Reimbursement Scenario—European Union 5 (EU5)

Reimbursement Scenario—European Union 5 (EU5) (continued)

NIPT Test Pricing Analysis by Country—2023

Competitive Environment

Key Competitors

Europe’s NIPT Market Competitive Landscape

Europe’s NIPT Market Competitive Landscape by Player

Competitive Mapping by NIPT Offering Parameters

Competitive Mapping by NIPT Offering Parameters (continued)

Comparison with the US Market

Europe’s NIPT Market—Notable Activities

Competitors—NIPT Business Reviews and Milestones

Companies to Watch—BGI Bioscience

Companies to Watch—Illumina

Companies to Watch—PerkinElmer

Companies to Watch—Roche Diagnostics

Companies to Watch—Eurofins LifeCodexx GmbH

Companies to Watch—Yourgene Health Plc (Novacyt)

Companies to Watch—Cradle Genomics

Companies to Watch—Natera, Inc.

Companies to Watch—Quest Diagnostics

Companies to Watch—NIPD Genetics

Companies to Watch—Progenity (Biora Therapeutics, Inc.)

Companies to Watch—Everly Health

Companies to Watch—Labcorp

Industry Mega Trends

Growth Opportunity Summary

Growth Opportunity 1: eCommerce and DTC Sales

Growth Opportunity 1: eCommerce and DTC Sales (continued)

Growth Opportunity 2: Partnerships and Joint Ventures with Local Labs in Europe

Growth Opportunity 2: Partnerships and Joint Ventures with Local Labs in Europe (continued)

Growth Opportunity 3: Low-Cost Solutions Leading to Cost-efficiency and Accessibility for Market Expansion

Growth Opportunity 3: Low-Cost Solutions Leading to Cost-efficiency and Accessibility for Market Expansion (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products non-invasive nature compared to traditional invasive prenatal testing methods like amniocentesis or chorionic villus sampling (CVS). In recent years, the European NIPT market has displayed a notable trend toward personalized medicine. Technological innovations have led to the development of advanced NIPT tests that offer higher accuracy in detecting chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Additionally, the growing preference for early and non-invasive prenatal screening has significantly contributed to the market's expansion. The intense competition within the NIPT industry in Europe is fueled by advancements in technology bioinformatics, artificial intelligence, next-generation sequencing (NGS) and the growing need for precise prenatal diagnostics. Additionally, the competitive environment becomes harsher due to broad market penetration, operational efficacy, and innovation. Rising startups are changing the industry by bringing innovative technology like exclusive platforms and AI-powered analytics to meet certain unmet demands. NIPD Genetics and other notable firms are at the forefront of innovation in the field, pioneering innovative testing.
More Information
Deliverable Type Market Research
Author Chandni Hussain
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Prenatal Testing Trends
Keyword 2 Non-Invasive Testing Industry Insights
Keyword 3 Healthcare Technology Trends
Podcast No
WIP Number MH32-01-00-00-00